Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Lipocine Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −3 vs. Q2 2023
- Shares held
- 499.9K
- +22.4K (+4.7%) vs. Q2 2023
- Total value
- $1.48M
- −$915.6K (−38.1%) vs. Q2 2023
- New holders
- 2
- 6 more added
- Sold out
- 5
- 5 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LPCN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $7.63M |
| Q1 2026 | 47 | $24.9M |
| Q4 2025 | 26 | $13.1M |
| Q3 2025 | 22 | $1.51M |
| Q2 2025 | 18 | $1.67M |
| Q1 2025 | 19 | $1.65M |
| Q4 2024 | 17 | $2.38M |
| Q3 2024 | 18 | $2.44M |
| Q2 2024 | 19 | $4.38M |
| Q1 2024 | 18 | $2.46M |
| Q4 2023 | 19 | $1.35M |
| Q3 2023 | 21 | $1.48M |
| Q2 2023 | 24 | $2.40M |
| Q1 2023 | 45 | $3.17M |
| Q4 2022 | 49 | $4.16M |
| Q3 2022 | 46 | $4.85M |
| Q2 2022 | 46 | $9.54M |
| Q1 2022 | 44 | $16.2M |
| Q4 2021 | 39 | $10.5M |
| Q3 2021 | 38 | $10.0M |
| Q2 2021 | 33 | $12.8M |
| Q1 2021 | 42 | $12.4M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Lipocine Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 77 | $0 | 0.00% | −4−4.9% | Reduced |
| Wells Fargo & Company | 39 | $116 | 0.00% | +2+5.4% | Added |
| UBS Group AG | 42 | $125 | 0.00% | +42 | New |
| Group One Trading, L.P. | 52 | $153 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 59 | $173 | 0.00% | +50+555.6% | Added |
| Bank of America Corp | 59 | $176 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 68 | $201 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 183 | $538 | 0.00% | +6+3.4% | Added |
| Tower Research Capital LLC (TRC) | 254 | $757 | 0.00% | −1,577−86.1% | Reduced |
| Caldwell Sutter Capital, Inc. | 471 | $1.40K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 765 | $2.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 722 | $2.15K | 0.00% | −425−37.1% | Reduced |
| Renaissance Technologies LLC | 15,597 | $46.0K | 0.00% | +5,200+50.0% | Added |
| Kestra Advisory Services, LLC | 16,703 | $49.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 18,626 | $54.8K | 0.00% | 00.0% | Unchanged |
| Wealth Effects LLC | 18,761 | $55.9K | 0.03% | −10,512−35.9% | Reduced |
| Susquehanna International Group, LLP | 25,329 | $74.5K | 0.00% | +14,335+130.4% | Added |
| Geode Capital Management, LLC | 48,854 | $143.7K | 0.00% | +240.0% | Added |
| Two Sigma Advisers, LP | 56,922 | $169.6K | 0.00% | +56,922 | New |
| BlackRock Inc. | 74,846 | $223.0K | 0.00% | −5,452−6.8% | Reduced |
| Vanguard Group Inc | 221,459 | $659.9K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −24,665−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −11,033−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −466−100.0% | Sold out |
| NewSquare Capital LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −83−100.0% | Sold out |